FDA Warning Letter — PREMIUM NATURE

Case 630110 — FEI 3016957059

The FDA took a Warning Letter action against PREMIUM NATURE on Sep 1, 2022 (South Plainfield, NJ). The action was issued by CDER and concerns drugs products.

Action details

Facility
PREMIUM NATURE
Date
Sep 1, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
South Plainfield, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.